Cargando…

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

PURPOSE: Advanced-stage mucinous ovarian carcinoma (MOC) has poor chemotherapy response and prognosis and lacks biomarkers to aid stage I adjuvant treatment. Differentiating primary MOC from gastrointestinal (GI) metastases to the ovary is also challenging due to phenotypic similarities. Clinicopath...

Descripción completa

Detalles Bibliográficos
Autores principales: Meagher, Nicola S., Gorringe, Kylie L., Wakefield, Matthew, Bolithon, Adelyn, Pang, Chi Nam Ignatius, Chiu, Derek S., Anglesio, Michael S., Mallitt, Kylie-Ann, Doherty, Jennifer A., Harris, Holly R., Schildkraut, Joellen M., Berchuck, Andrew, Cushing-Haugen, Kara L., Chezar, Ksenia, Chou, Angela, Tan, Adeline, Alsop, Jennifer, Barlow, Ellen, Beckmann, Matthias W., Boros, Jessica, Bowtell, David D.L., Brand, Alison H., Brenton, James D., Campbell, Ian, Cheasley, Dane, Cohen, Joshua, Cybulski, Cezary, Elishaev, Esther, Erber, Ramona, Farrell, Rhonda, Fischer, Anna, Fu, Zhuxuan, Gilks, Blake, Gill, Anthony J., Gourley, Charlie, Grube, Marcel, Harnett, Paul R., Hartmann, Arndt, Hettiaratchi, Anusha, Høgdall, Claus K., Huzarski, Tomasz, Jakubowska, Anna, Jimenez-Linan, Mercedes, Kennedy, Catherine J., Kim, Byoung-Gie, Kim, Jae-Weon, Kim, Jae-Hoon, Klett, Kayla, Koziak, Jennifer M., Lai, Tiffany, Laslavic, Angela, Lester, Jenny, Leung, Yee, Li, Na, Liauw, Winston, Lim, Belle W.X., Linder, Anna, Lubiński, Jan, Mahale, Sakshi, Mateoiu, Constantina, McInerny, Simone, Menkiszak, Janusz, Minoo, Parham, Mittelstadt, Suzana, Morris, David, Orsulic, Sandra, Park, Sang-Yoon, Pearce, Celeste Leigh, Pearson, John V., Pike, Malcolm C., Quinn, Carmel M., Mohan, Ganendra Raj, Rao, Jianyu, Riggan, Marjorie J., Ruebner, Matthias, Salfinger, Stuart, Scott, Clare L., Shah, Mitul, Steed, Helen, Stewart, Colin J.R., Subramanian, Deepak, Sung, Soseul, Tang, Katrina, Timpson, Paul, Ward, Robyn L., Wiedenhoefer, Rebekka, Thorne, Heather, Cohen, Paul A., Crowe, Philip, Fasching, Peter A., Gronwald, Jacek, Hawkins, Nicholas J., Høgdall, Estrid, Huntsman, David G., James, Paul A., Karlan, Beth Y., Kelemen, Linda E., Kommoss, Stefan, Konecny, Gottfried E., Modugno, Francesmary, Park, Sue K., Staebler, Annette, Sundfeldt, Karin, Wu, Anna H., Talhouk, Aline, Pharoah, Paul D.P., Anderson, Lyndal, DeFazio, Anna, Köbel, Martin, Friedlander, Michael L., Ramus, Susan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751776/
https://www.ncbi.nlm.nih.gov/pubmed/36222710
http://dx.doi.org/10.1158/1078-0432.CCR-22-1206
_version_ 1784850555238088704
author Meagher, Nicola S.
Gorringe, Kylie L.
Wakefield, Matthew
Bolithon, Adelyn
Pang, Chi Nam Ignatius
Chiu, Derek S.
Anglesio, Michael S.
Mallitt, Kylie-Ann
Doherty, Jennifer A.
Harris, Holly R.
Schildkraut, Joellen M.
Berchuck, Andrew
Cushing-Haugen, Kara L.
Chezar, Ksenia
Chou, Angela
Tan, Adeline
Alsop, Jennifer
Barlow, Ellen
Beckmann, Matthias W.
Boros, Jessica
Bowtell, David D.L.
Brand, Alison H.
Brenton, James D.
Campbell, Ian
Cheasley, Dane
Cohen, Joshua
Cybulski, Cezary
Elishaev, Esther
Erber, Ramona
Farrell, Rhonda
Fischer, Anna
Fu, Zhuxuan
Gilks, Blake
Gill, Anthony J.
Gourley, Charlie
Grube, Marcel
Harnett, Paul R.
Hartmann, Arndt
Hettiaratchi, Anusha
Høgdall, Claus K.
Huzarski, Tomasz
Jakubowska, Anna
Jimenez-Linan, Mercedes
Kennedy, Catherine J.
Kim, Byoung-Gie
Kim, Jae-Weon
Kim, Jae-Hoon
Klett, Kayla
Koziak, Jennifer M.
Lai, Tiffany
Laslavic, Angela
Lester, Jenny
Leung, Yee
Li, Na
Liauw, Winston
Lim, Belle W.X.
Linder, Anna
Lubiński, Jan
Mahale, Sakshi
Mateoiu, Constantina
McInerny, Simone
Menkiszak, Janusz
Minoo, Parham
Mittelstadt, Suzana
Morris, David
Orsulic, Sandra
Park, Sang-Yoon
Pearce, Celeste Leigh
Pearson, John V.
Pike, Malcolm C.
Quinn, Carmel M.
Mohan, Ganendra Raj
Rao, Jianyu
Riggan, Marjorie J.
Ruebner, Matthias
Salfinger, Stuart
Scott, Clare L.
Shah, Mitul
Steed, Helen
Stewart, Colin J.R.
Subramanian, Deepak
Sung, Soseul
Tang, Katrina
Timpson, Paul
Ward, Robyn L.
Wiedenhoefer, Rebekka
Thorne, Heather
Cohen, Paul A.
Crowe, Philip
Fasching, Peter A.
Gronwald, Jacek
Hawkins, Nicholas J.
Høgdall, Estrid
Huntsman, David G.
James, Paul A.
Karlan, Beth Y.
Kelemen, Linda E.
Kommoss, Stefan
Konecny, Gottfried E.
Modugno, Francesmary
Park, Sue K.
Staebler, Annette
Sundfeldt, Karin
Wu, Anna H.
Talhouk, Aline
Pharoah, Paul D.P.
Anderson, Lyndal
DeFazio, Anna
Köbel, Martin
Friedlander, Michael L.
Ramus, Susan J.
author_facet Meagher, Nicola S.
Gorringe, Kylie L.
Wakefield, Matthew
Bolithon, Adelyn
Pang, Chi Nam Ignatius
Chiu, Derek S.
Anglesio, Michael S.
Mallitt, Kylie-Ann
Doherty, Jennifer A.
Harris, Holly R.
Schildkraut, Joellen M.
Berchuck, Andrew
Cushing-Haugen, Kara L.
Chezar, Ksenia
Chou, Angela
Tan, Adeline
Alsop, Jennifer
Barlow, Ellen
Beckmann, Matthias W.
Boros, Jessica
Bowtell, David D.L.
Brand, Alison H.
Brenton, James D.
Campbell, Ian
Cheasley, Dane
Cohen, Joshua
Cybulski, Cezary
Elishaev, Esther
Erber, Ramona
Farrell, Rhonda
Fischer, Anna
Fu, Zhuxuan
Gilks, Blake
Gill, Anthony J.
Gourley, Charlie
Grube, Marcel
Harnett, Paul R.
Hartmann, Arndt
Hettiaratchi, Anusha
Høgdall, Claus K.
Huzarski, Tomasz
Jakubowska, Anna
Jimenez-Linan, Mercedes
Kennedy, Catherine J.
Kim, Byoung-Gie
Kim, Jae-Weon
Kim, Jae-Hoon
Klett, Kayla
Koziak, Jennifer M.
Lai, Tiffany
Laslavic, Angela
Lester, Jenny
Leung, Yee
Li, Na
Liauw, Winston
Lim, Belle W.X.
Linder, Anna
Lubiński, Jan
Mahale, Sakshi
Mateoiu, Constantina
McInerny, Simone
Menkiszak, Janusz
Minoo, Parham
Mittelstadt, Suzana
Morris, David
Orsulic, Sandra
Park, Sang-Yoon
Pearce, Celeste Leigh
Pearson, John V.
Pike, Malcolm C.
Quinn, Carmel M.
Mohan, Ganendra Raj
Rao, Jianyu
Riggan, Marjorie J.
Ruebner, Matthias
Salfinger, Stuart
Scott, Clare L.
Shah, Mitul
Steed, Helen
Stewart, Colin J.R.
Subramanian, Deepak
Sung, Soseul
Tang, Katrina
Timpson, Paul
Ward, Robyn L.
Wiedenhoefer, Rebekka
Thorne, Heather
Cohen, Paul A.
Crowe, Philip
Fasching, Peter A.
Gronwald, Jacek
Hawkins, Nicholas J.
Høgdall, Estrid
Huntsman, David G.
James, Paul A.
Karlan, Beth Y.
Kelemen, Linda E.
Kommoss, Stefan
Konecny, Gottfried E.
Modugno, Francesmary
Park, Sue K.
Staebler, Annette
Sundfeldt, Karin
Wu, Anna H.
Talhouk, Aline
Pharoah, Paul D.P.
Anderson, Lyndal
DeFazio, Anna
Köbel, Martin
Friedlander, Michael L.
Ramus, Susan J.
author_sort Meagher, Nicola S.
collection PubMed
description PURPOSE: Advanced-stage mucinous ovarian carcinoma (MOC) has poor chemotherapy response and prognosis and lacks biomarkers to aid stage I adjuvant treatment. Differentiating primary MOC from gastrointestinal (GI) metastases to the ovary is also challenging due to phenotypic similarities. Clinicopathologic and gene-expression data were analyzed to identify prognostic and diagnostic features. EXPERIMENTAL DESIGN: Discovery analyses selected 19 genes with prognostic/diagnostic potential. Validation was performed through the Ovarian Tumor Tissue Analysis consortium and GI cancer biobanks comprising 604 patients with MOC (n = 333), mucinous borderline ovarian tumors (MBOT, n = 151), and upper GI (n = 65) and lower GI tumors (n = 55). RESULTS: Infiltrative pattern of invasion was associated with decreased overall survival (OS) within 2 years from diagnosis, compared with expansile pattern in stage I MOC [hazard ratio (HR), 2.77; 95% confidence interval (CI), 1.04–7.41, P = 0.042]. Increased expression of THBS2 and TAGLN was associated with shorter OS in MOC patients (HR, 1.25; 95% CI, 1.04–1.51, P = 0.016) and (HR, 1.21; 95% CI, 1.01–1.45, P = 0.043), respectively. ERBB2 (HER2) amplification or high mRNA expression was evident in 64 of 243 (26%) of MOCs, but only 8 of 243 (3%) were also infiltrative (4/39, 10%) or stage III/IV (4/31, 13%). CONCLUSIONS: An infiltrative growth pattern infers poor prognosis within 2 years from diagnosis and may help select stage I patients for adjuvant therapy. High expression of THBS2 and TAGLN in MOC confers an adverse prognosis and is upregulated in the infiltrative subtype, which warrants further investigation. Anti-HER2 therapy should be investigated in a subset of patients. MOC samples clustered with upper GI, yet markers to differentiate these entities remain elusive, suggesting similar underlying biology and shared treatment strategies.
format Online
Article
Text
id pubmed-9751776
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association for Cancer Research
record_format MEDLINE/PubMed
spelling pubmed-97517762023-01-05 Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes Meagher, Nicola S. Gorringe, Kylie L. Wakefield, Matthew Bolithon, Adelyn Pang, Chi Nam Ignatius Chiu, Derek S. Anglesio, Michael S. Mallitt, Kylie-Ann Doherty, Jennifer A. Harris, Holly R. Schildkraut, Joellen M. Berchuck, Andrew Cushing-Haugen, Kara L. Chezar, Ksenia Chou, Angela Tan, Adeline Alsop, Jennifer Barlow, Ellen Beckmann, Matthias W. Boros, Jessica Bowtell, David D.L. Brand, Alison H. Brenton, James D. Campbell, Ian Cheasley, Dane Cohen, Joshua Cybulski, Cezary Elishaev, Esther Erber, Ramona Farrell, Rhonda Fischer, Anna Fu, Zhuxuan Gilks, Blake Gill, Anthony J. Gourley, Charlie Grube, Marcel Harnett, Paul R. Hartmann, Arndt Hettiaratchi, Anusha Høgdall, Claus K. Huzarski, Tomasz Jakubowska, Anna Jimenez-Linan, Mercedes Kennedy, Catherine J. Kim, Byoung-Gie Kim, Jae-Weon Kim, Jae-Hoon Klett, Kayla Koziak, Jennifer M. Lai, Tiffany Laslavic, Angela Lester, Jenny Leung, Yee Li, Na Liauw, Winston Lim, Belle W.X. Linder, Anna Lubiński, Jan Mahale, Sakshi Mateoiu, Constantina McInerny, Simone Menkiszak, Janusz Minoo, Parham Mittelstadt, Suzana Morris, David Orsulic, Sandra Park, Sang-Yoon Pearce, Celeste Leigh Pearson, John V. Pike, Malcolm C. Quinn, Carmel M. Mohan, Ganendra Raj Rao, Jianyu Riggan, Marjorie J. Ruebner, Matthias Salfinger, Stuart Scott, Clare L. Shah, Mitul Steed, Helen Stewart, Colin J.R. Subramanian, Deepak Sung, Soseul Tang, Katrina Timpson, Paul Ward, Robyn L. Wiedenhoefer, Rebekka Thorne, Heather Cohen, Paul A. Crowe, Philip Fasching, Peter A. Gronwald, Jacek Hawkins, Nicholas J. Høgdall, Estrid Huntsman, David G. James, Paul A. Karlan, Beth Y. Kelemen, Linda E. Kommoss, Stefan Konecny, Gottfried E. Modugno, Francesmary Park, Sue K. Staebler, Annette Sundfeldt, Karin Wu, Anna H. Talhouk, Aline Pharoah, Paul D.P. Anderson, Lyndal DeFazio, Anna Köbel, Martin Friedlander, Michael L. Ramus, Susan J. Clin Cancer Res Precision Medicine and Imaging PURPOSE: Advanced-stage mucinous ovarian carcinoma (MOC) has poor chemotherapy response and prognosis and lacks biomarkers to aid stage I adjuvant treatment. Differentiating primary MOC from gastrointestinal (GI) metastases to the ovary is also challenging due to phenotypic similarities. Clinicopathologic and gene-expression data were analyzed to identify prognostic and diagnostic features. EXPERIMENTAL DESIGN: Discovery analyses selected 19 genes with prognostic/diagnostic potential. Validation was performed through the Ovarian Tumor Tissue Analysis consortium and GI cancer biobanks comprising 604 patients with MOC (n = 333), mucinous borderline ovarian tumors (MBOT, n = 151), and upper GI (n = 65) and lower GI tumors (n = 55). RESULTS: Infiltrative pattern of invasion was associated with decreased overall survival (OS) within 2 years from diagnosis, compared with expansile pattern in stage I MOC [hazard ratio (HR), 2.77; 95% confidence interval (CI), 1.04–7.41, P = 0.042]. Increased expression of THBS2 and TAGLN was associated with shorter OS in MOC patients (HR, 1.25; 95% CI, 1.04–1.51, P = 0.016) and (HR, 1.21; 95% CI, 1.01–1.45, P = 0.043), respectively. ERBB2 (HER2) amplification or high mRNA expression was evident in 64 of 243 (26%) of MOCs, but only 8 of 243 (3%) were also infiltrative (4/39, 10%) or stage III/IV (4/31, 13%). CONCLUSIONS: An infiltrative growth pattern infers poor prognosis within 2 years from diagnosis and may help select stage I patients for adjuvant therapy. High expression of THBS2 and TAGLN in MOC confers an adverse prognosis and is upregulated in the infiltrative subtype, which warrants further investigation. Anti-HER2 therapy should be investigated in a subset of patients. MOC samples clustered with upper GI, yet markers to differentiate these entities remain elusive, suggesting similar underlying biology and shared treatment strategies. American Association for Cancer Research 2022-12-15 2022-10-07 /pmc/articles/PMC9751776/ /pubmed/36222710 http://dx.doi.org/10.1158/1078-0432.CCR-22-1206 Text en ©2022 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by/4.0/This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
spellingShingle Precision Medicine and Imaging
Meagher, Nicola S.
Gorringe, Kylie L.
Wakefield, Matthew
Bolithon, Adelyn
Pang, Chi Nam Ignatius
Chiu, Derek S.
Anglesio, Michael S.
Mallitt, Kylie-Ann
Doherty, Jennifer A.
Harris, Holly R.
Schildkraut, Joellen M.
Berchuck, Andrew
Cushing-Haugen, Kara L.
Chezar, Ksenia
Chou, Angela
Tan, Adeline
Alsop, Jennifer
Barlow, Ellen
Beckmann, Matthias W.
Boros, Jessica
Bowtell, David D.L.
Brand, Alison H.
Brenton, James D.
Campbell, Ian
Cheasley, Dane
Cohen, Joshua
Cybulski, Cezary
Elishaev, Esther
Erber, Ramona
Farrell, Rhonda
Fischer, Anna
Fu, Zhuxuan
Gilks, Blake
Gill, Anthony J.
Gourley, Charlie
Grube, Marcel
Harnett, Paul R.
Hartmann, Arndt
Hettiaratchi, Anusha
Høgdall, Claus K.
Huzarski, Tomasz
Jakubowska, Anna
Jimenez-Linan, Mercedes
Kennedy, Catherine J.
Kim, Byoung-Gie
Kim, Jae-Weon
Kim, Jae-Hoon
Klett, Kayla
Koziak, Jennifer M.
Lai, Tiffany
Laslavic, Angela
Lester, Jenny
Leung, Yee
Li, Na
Liauw, Winston
Lim, Belle W.X.
Linder, Anna
Lubiński, Jan
Mahale, Sakshi
Mateoiu, Constantina
McInerny, Simone
Menkiszak, Janusz
Minoo, Parham
Mittelstadt, Suzana
Morris, David
Orsulic, Sandra
Park, Sang-Yoon
Pearce, Celeste Leigh
Pearson, John V.
Pike, Malcolm C.
Quinn, Carmel M.
Mohan, Ganendra Raj
Rao, Jianyu
Riggan, Marjorie J.
Ruebner, Matthias
Salfinger, Stuart
Scott, Clare L.
Shah, Mitul
Steed, Helen
Stewart, Colin J.R.
Subramanian, Deepak
Sung, Soseul
Tang, Katrina
Timpson, Paul
Ward, Robyn L.
Wiedenhoefer, Rebekka
Thorne, Heather
Cohen, Paul A.
Crowe, Philip
Fasching, Peter A.
Gronwald, Jacek
Hawkins, Nicholas J.
Høgdall, Estrid
Huntsman, David G.
James, Paul A.
Karlan, Beth Y.
Kelemen, Linda E.
Kommoss, Stefan
Konecny, Gottfried E.
Modugno, Francesmary
Park, Sue K.
Staebler, Annette
Sundfeldt, Karin
Wu, Anna H.
Talhouk, Aline
Pharoah, Paul D.P.
Anderson, Lyndal
DeFazio, Anna
Köbel, Martin
Friedlander, Michael L.
Ramus, Susan J.
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
title Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
title_full Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
title_fullStr Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
title_full_unstemmed Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
title_short Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
title_sort gene-expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes
topic Precision Medicine and Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751776/
https://www.ncbi.nlm.nih.gov/pubmed/36222710
http://dx.doi.org/10.1158/1078-0432.CCR-22-1206
work_keys_str_mv AT meaghernicolas geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT gorringekyliel geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT wakefieldmatthew geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT bolithonadelyn geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT pangchinamignatius geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT chiudereks geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT anglesiomichaels geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT mallittkylieann geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT dohertyjennifera geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT harrishollyr geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT schildkrautjoellenm geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT berchuckandrew geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT cushinghaugenkaral geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT chezarksenia geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT chouangela geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT tanadeline geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT alsopjennifer geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT barlowellen geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT beckmannmatthiasw geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT borosjessica geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT bowtelldaviddl geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT brandalisonh geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT brentonjamesd geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT campbellian geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT cheasleydane geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT cohenjoshua geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT cybulskicezary geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT elishaevesther geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT erberramona geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT farrellrhonda geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT fischeranna geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT fuzhuxuan geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT gilksblake geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT gillanthonyj geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT gourleycharlie geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT grubemarcel geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT harnettpaulr geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT hartmannarndt geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT hettiaratchianusha geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT høgdallclausk geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT huzarskitomasz geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT jakubowskaanna geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT jimenezlinanmercedes geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT kennedycatherinej geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT kimbyounggie geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT kimjaeweon geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT kimjaehoon geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT klettkayla geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT koziakjenniferm geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT laitiffany geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT laslavicangela geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT lesterjenny geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT leungyee geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT lina geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT liauwwinston geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT limbellewx geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT linderanna geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT lubinskijan geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT mahalesakshi geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT mateoiuconstantina geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT mcinernysimone geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT menkiszakjanusz geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT minooparham geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT mittelstadtsuzana geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT morrisdavid geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT orsulicsandra geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT parksangyoon geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT pearcecelesteleigh geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT pearsonjohnv geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT pikemalcolmc geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT quinncarmelm geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT mohanganendraraj geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT raojianyu geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT rigganmarjoriej geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT ruebnermatthias geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT salfingerstuart geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT scottclarel geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT shahmitul geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT steedhelen geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT stewartcolinjr geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT subramaniandeepak geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT sungsoseul geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT tangkatrina geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT timpsonpaul geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT wardrobynl geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT wiedenhoeferrebekka geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT thorneheather geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT cohenpaula geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT crowephilip geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT faschingpetera geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT gronwaldjacek geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT hawkinsnicholasj geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT høgdallestrid geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT huntsmandavidg geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT jamespaula geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT karlanbethy geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT kelemenlindae geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT kommossstefan geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT konecnygottfriede geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT modugnofrancesmary geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT parksuek geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT staeblerannette geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT sundfeldtkarin geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT wuannah geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT talhoukaline geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT pharoahpauldp geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT andersonlyndal geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT defazioanna geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT kobelmartin geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT friedlandermichaell geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes
AT ramussusanj geneexpressionprofilingofmucinousovariantumorsandcomparisonwithupperandlowergastrointestinaltumorsidentifiesmarkersassociatedwithadverseoutcomes